Table 1. Patient baseline characteristics (n = 20).
VariableOverallTreatment
Age (years)50 (12)
Sex
    Male13 (65)3 D/10 Va
    Female7 (35)2 D/5 V
Stage
    Unresectable IIIc1 (5)0 D/1 V
    IVa5 (25)2 D/3 V
    IVb1 (5)0 D/1 V
    IVc13 (65)3 D/10 V
Primary site
    Cutaneous16 (80)4 D/12 V
    Mucosal0 (0)0 D/0 V
    Uveal0 (0)0 D/0 V
    Acral2 (10)0 D/2 V
    Unknown2 (10)1 D/1 V
  • Data are mean (SD) or n (%).

  • a D, dabrafenib; V, vemurafenib.